Inventor · disambiguated record
Samuel R. Denmeade
Also filed as: DENMEADE SAMUEL R · DENMEADE SAMUEL RAY
24 granted patents·13 pending applications·364 citations·filing 1998–2022
96Inventor score
Top patents by PatentIndex Score
37 records- 0197US7635682B2Tumor activated prodrugsGENSPERA INC·Filed 2006·Granted Dec 22, 2009·63 cites·19 claims
- 0294US6265540B1Tissue specific prodrugUNIV JOHNS HOPKINS MED·Filed 1998·Granted Jul 24, 2001·78 cites·17 claims
- 0390US8772226B2Methods and compositions for the detection of cancerDENMEADE SAMUEL RAY·Filed 2010·Granted Jul 8, 2014·36 cites·45 claims
- 0490US6545131B1Tissue specific prodrugUNIV JOHNS HOPKINS·Filed 2000·Granted Apr 8, 2003·29 cites·21 claims
- 0589US6504014B1Tissue specific prodrugUNIV JOHNS HOPKINS·Filed 2000·Granted Jan 7, 2003·30 cites·14 claims
- 0689US6410514B1Tissue specific prodrugUNIV JOHNS HOPKINS·Filed 2000·Granted Jun 25, 2002·23 cites·33 claims
- 0788US8258256B2Compositions and methods for the treatment of cancerDENMEADE SAMUEL R·Filed 2007·Granted Sep 4, 2012·10 cites·12 claims
- 0888US7838266B2Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancerUNIV VICTORIA INNOVAT DEV·Filed 2010·Granted Nov 23, 2010·6 cites·19 claims
- 0988US7468354B2Tissue specific prodrugsGENSPERA INC·Filed 2001·Granted Dec 23, 2008·17 cites·2 claims
- 1088US7053042B1Activation of peptide prodrugs by hK2DENMEADE SAMUEL R·Filed 2000·Granted May 30, 2006·20 cites·40 claims
- 1187US9422234B2Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancerCHANDRAN SACHIN S·Filed 2008·Granted Aug 23, 2016·14 cites·26 claims
- 1287US7767648B2Tissue specific prodrugsGENSPERA INC·Filed 2008·Granted Aug 3, 2010·7 cites·11 claims
- 1387US7282476B2Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancerUNIV JOHNS HOPKINS·Filed 2002·Granted Oct 16, 2007·15 cites·36 claims
- 1485US10369113B2Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancerUNIV JOHNS HOPKINS·Filed 2016·Granted Aug 6, 2019·4 cites·19 claims
- 1581US7745395B2Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancerUNIV VICTORIA INNOVATIION AND·Filed 2007·Granted Jun 29, 2010·6 cites·30 claims
- 1678US7906477B2Activation of peptide prodrugs by hK2GENSPERA INC·Filed 2003·Granted Mar 15, 2011·4 cites·28 claims
- 1776US2010120697A1Tumor Activated ProdrugsDENMEADE SAMUEL R·Filed 2009·Application pending·0 cites
- 1873US9492560B2Emetine derivatives, prodrugs containing same, and methods of treating conditions using sameBAKARE OLADAPO·Filed 2013·Granted Nov 15, 2016·2 cites·2 claims
- 1966US2010047170A1Peptide ProdrugsDENMEADE SAMUEL R·Filed 2007·Application pending·0 cites
- 2065US10967046B2Albumin-proaerolysin prodrugsUNIV JOHNS HOPKINS·Filed 2020·Granted Apr 6, 2021·0 cites·12 claims
- 2165US8957016B2Tumor activated prodrugsDENMEADE SAMUEL R·Filed 2012·Granted Feb 17, 2015·0 cites·31 claims
- 2265US8822406B2Tumor activated prodrugsDENMEADE SAMUEL R·Filed 2012·Granted Sep 2, 2014·0 cites·31 claims
- 2364US2014087991A1Peptide prodrugsUNIV JOHNS HOPKINS·Filed 2013·Application pending·0 cites
- 2463US2021205408A1Albumin-proaerolysin prodrugsUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 2559US11780833B2Emetine derivatives, prodrugs containing same, and methods of treating conditions using sameUNIV HOWARD·Filed 2018·Granted Oct 10, 2023·0 cites·8 claims
- 2659US2008247950A1Activation of peptide prodrugs by hK2GENSPERA INC·Filed 2007·Application pending·0 cites
- 2758US8669231B2Activation of peptide prodrugs by hK2DENMEADE SAMUEL R·Filed 2011·Granted Mar 11, 2014·0 cites·7 claims
- 2856US8450280B2Activation of peptide prodrugs by hK2DENMEADE SAMUEL R·Filed 2012·Granted May 28, 2013·0 cites·19 claims
- 2955US2006183689A1Activation of peptide prodrugs by hK2DENMEADE SAMUEL R·Filed 2005·Application pending·0 cites
- 3054US2025281509A1Sequential hormone therapy to improve survival and enhance response to immune therapy in men with prostate cancerUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 3153US10596226B2Albumin-proaerolysin prodrugsUNIV JOHNS HOPKINS·Filed 2016·Granted Mar 24, 2020·0 cites·3 claims
- 3252US2012283166A1Peptide prodrugsDENMEADE SAMUEL R·Filed 2012·Application pending·0 cites
- 3352US2020170960A1Prostate specific membrane antigen (psma) targeted nanoparticles for therapy of prostate cancerUNIV JOHNS HOPKINS·Filed 2019·Application pending·0 cites
- 3449US2023331694A1Fap-activated compounds for treatment of cancerUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 3547US2017190700A1Emetine Derivatives, Prodrugs Containing Same, And Methods Of Treating Conditions Using SameBAKARE OLADAPO·Filed 2016·Application pending·0 cites
- 3643US2006058250A1Methods of treating proliferative skin diseases using carbazole derivativesCEPHALON INC·Filed 2005·Application pending·0 cites
- 3738US2018148480A1Synthetic enhancement of the t-cell armamentarium as an anti-cancer therapyUNIV JOHNS HOPKINS·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Samuel R. Denmeade files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →